CYTR
CYTRX CORP
stockOTC
InactiveOct 5, 2022
0.092USD0.000%(0.00)4,048
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Steven Kriegsman
HQ
Los Angeles, California, USA
Nov 1, 2017 · 1-for-6 (reverse)
CYTR Profile
CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).
CYTR Performance
| Period | Price | Date | Change |
|---|